We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $97.9B
1-Year Est. Return 20.73%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+16.81%
1 Year Est. Return
+20.73%
3 Year Est. Return
+127.31%
5 Year Est. Return
+136.48%
10 Year Est. Return
+1,577.48%
AUM
$68.7B
AUM Growth
+$7.93B
Cap. Flow
-$1.14B
Cap. Flow %
-1.65%
Top 10 Hldgs %
49.77%
Holding
211
New
13
Increased
53
Reduced
100
Closed
11

Top Sells

Rank Stock Value
1
FRC
First Republic Bank
FRC
+$416M
2
QGENF
QIAGEN NV
QGENF
+$213M
3
AMZN icon
Amazon
AMZN
+$209M
4
STLA icon
Stellantis
STLA
+$180M
5
TRIP icon
TripAdvisor
TRIP
+$110M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.34%
2 Communication Services 17.69%
3 Healthcare 14.09%
4 Technology 9.35%
5 Financials 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWT icon
151
California Water Service
CWT
$3.1B
$10.2M 0.01%
284,124
-128,526
-31% -$4.45M
AWK icon
152
American Water Works
AWK
$26.7B
$9.85M 0.01%
126,634
+724
+0.6% +$53.8K
PCRX icon
153
Pacira BioSciences
PCRX
$1.04B
$9.74M 0.01%
213,600
ALB icon
154
Albemarle
ALB
$13.9B
$9.71M 0.01%
+91,905
New +$8.94M
BMY icon
155
Bristol-Myers Squibb
BMY
$133B
$9.67M 0.01%
177,742
-8,639
-5% -$474K
EL icon
156
Estee Lauder
EL
$30.4B
$9.46M 0.01%
111,584
SLB icon
157
SLB Ltd
SLB
$73.6B
$9.3M 0.01%
119,127
VAR
158
DELISTED
Varian Medical Systems, Inc.
VAR
$9.17M 0.01%
100,667
-14,132
-12% -$1.18M
PX
159
DELISTED
Praxair Inc
PX
$8.33M 0.01%
70,221
AVAV icon
160
AeroVironment
AVAV
$7.56B
$8.06M 0.01%
287,710
LTRPA
161
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$7.66M 0.01%
543,314
STMP
162
DELISTED
Stamps.com, Inc.
STMP
$7.17M 0.01%
60,550
-3,000
-5% -$371K
CSLT
163
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$6.55M 0.01%
1,794,820
FARO
164
DELISTED
Faro Technologies
FARO
$6.22M 0.01%
174,080
MCHP icon
165
Microchip Technology
MCHP
$40.3B
$6.1M 0.01%
165,320
LXFT
166
DELISTED
Luxoft Holding, Inc.
LXFT
$6.06M 0.01%
96,930
CDXS icon
167
Codexis
CDXS
$151M
$5.69M 0.01%
1,185,133
FMI
168
DELISTED
Foundation Medicine, Inc.
FMI
$5.64M 0.01%
174,800
NVDQ
169
DELISTED
Novadaq Technologies Inc.
NVDQ
$5.49M 0.01%
704,480
EXA
170
DELISTED
EXA Corporation
EXA
$5.33M 0.01%
419,630
ADAP
171
DELISTED
Adaptimmune Therapeutics
ADAP
$5.08M 0.01%
920,984
TDOC icon
172
Teladoc Health
TDOC
$1.22B
$5.08M 0.01%
+203,000
New +$4.22M
AMBA icon
173
Ambarella
AMBA
$3.77B
$4.88M 0.01%
+89,100
New +$4.81M
STAA icon
174
STAAR Surgical
STAA
$1.21B
$4.8M 0.01%
489,540
DMRC icon
175
Digimarc Corp
DMRC
$147M
$4.71M 0.01%
174,500

Similar funds

Baillie Gifford & Co's Q1 2017 Portfolio in Review

As of Q1 2017, Baillie Gifford & Co held 211 positions worth $68.7B, up 13% from $60.8B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Baillie Gifford & Co's Q1 2017 filing shows 13 new, 53 increased, 100 reduced and 11 closed positions. Its largest new stake was Qiagen: 6,818,876 shares worth $209M. The largest sale was First Republic Bank, an estimated $416M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, up from 35% a quarter earlier, followed by Communication Services and Healthcare.

  • Baillie Gifford & Co's largest Q1 2017 buy was Qiagen: 6,818,876 shares worth $209M.
  • Baillie Gifford & Co added most to Jefferies Financial Group in Q1 2017, an estimated $187M increase.
  • Baillie Gifford & Co's biggest Q1 2017 reduction was First Republic Bank, cutting an estimated $416M.
  • Baillie Gifford & Co fully exited QIAGEN NV in Q1 2017, selling an estimated $213M.
  • Baillie Gifford & Co's ten largest holdings make up 50% of its $68.7B portfolio in Q1 2017.
  • Baillie Gifford & Co opened 13 new positions and closed 11 in Q1 2017.
  • Baillie Gifford & Co's portfolio value rose 13% quarter-over-quarter to $68.7B.

Based on Baillie Gifford & Co's 13F filing for Q1 2017, filed 12 May 2017.